Abhay Soi Critiques Proposed Price Cap on Private Hospital Rooms

Max Healthcare Chairman Abhay Soi has voiced strong reservations about a proposed cap on room rents in private hospitals. Speaking during an earnings call, Soi emphasized the need to balance affordability with investment viability to ensure the expansion of healthcare facilities. His comments come in response to a recommendation from a Parliamentary panel suggesting room rates in private hospitals should not exceed the average rates of three-star hotels nearby.

Balancing Affordability and Investment

The Parliamentary Standing Committee on Health and Family Welfare recently put forward a report addressing the affordability and accessibility of healthcare services. The report advocates for limiting room charges in private hospitals to make healthcare more affordable. However, Soi argues that such a cap could deter investments needed for building new facilities. "Wise minds will think otherwise," he stated, indicating that a comprehensive evaluation of both affordability and the need for new hospital beds is essential.

Soi explained that the healthcare sector requires substantial capital investment, and any policy should create an environment conducive to such investments. He remains optimistic about Max Healthcare's position, suggesting that the company could benefit from potential industry consolidation if the price cap is implemented.

Hospital Admission Guidelines Under Scrutiny

In addition to addressing the price cap issue, Soi commented on new guidelines from the General Insurance Council (GIC) intended to reduce unnecessary hospitalizations. These guidelines aim to regulate when patients with common illnesses should be admitted and eligible for cashless insurance. Soi clarified that the decision to admit patients rests with doctors, not hospitals, and any standardization should involve the Indian Medical Association (IMA).

The Association of Healthcare Providers (India), representing over 21,000 hospitals, has expressed concerns about the guidelines, viewing them as advisory rather than mandatory. They caution against insurers using these guidelines to deny cashless approvals or reject claims, stressing that clinical decisions should remain with healthcare professionals.

Soi's remarks highlight the ongoing tension between regulatory efforts to control healthcare costs and the operational needs of private healthcare providers. As the debate continues, industry stakeholders are keenly watching how these proposed changes might affect the healthcare landscape in India.